ARCHIVES

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

This article is from The Cancer Letter archive.

Vol. 18 No. 28 | July 10, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible

May 26, 1995

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

In Brief: NBA, NCI Signs Agreement On Content OF PSAs; Broder Talks To NBA Wives; ASC Honors Frei

May 22, 1992